| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Radiology, University of Vienna, Waehringer Guertel 18-20,
A-1090 Vienna, Austria.
2 Department of Surgery, University of Vienna, A-1090 Vienna, Austria.
3 Department of Vascular/Interventional Radiology, Duke University Medical
Center, DUMC 3808, Durham, NC 27710.
4 Department of Internal Medicine 4, Division of Gastroenterology, University of
Vienna, A-1090 Vienna, Austria.
OBJECTIVE. The purpose of this study was to compare mangafodipir trisodium—enhanced MR imaging performed with a phased array coil and contrast-enhanced single-detector helical CT for accuracy in the detection and local staging of pancreatic adenocarcinoma and in the differentiation between cancer and focal pancreatitis.
SUBJECTS AND METHODS. Forty-two patients with suspected pancreatic masses underwent contrast-enhanced helical CT and mangafodipir trisodium—enhanced MR imaging at 1.5 T. The images were assessed for the presence or absence of tumors; characterization of masses; and presence of vascular invasion, lymph node metastases, or liver metastases. Imaging findings were correlated with findings at laparotomy, laparoscopy, biopsy, or follow-up.
RESULTS. Focal masses were present in 36 patients (cancer, n = 26; focal pancreatitis, n = 7; other, n = 3). The sensitivity for lesion detection of MR imaging was 100% and of CT, 94%. Two small malignant lesions were missed on CT. For the diagnosis of tumor nonresectability, the sensitivity of MR imaging and CT was 90% and 80%, respectively. Liver metastases were missed on MR imaging in one of the eight patients and on CT in four. For differentiation between adenocarcinoma and nonadenocarcinoma, the sensitivity of MR imaging was 100% (positive predictive value, 90%; negative predictive value, 100%), and the sensitivity of CT was 92% (positive predictive value, 80%; negative predictive value, 67%). Receiver operating characteristic analysis revealed that the mean area under the curve for MR imaging was 0.920 and for CT, 0.832 (not significant).
CONCLUSION. Mangafodipir trisodium—enhanced MR imaging is as accurate as contrast-enhanced helical CT for the detection and staging of pancreatic cancer but offers improved detection of small pancreatic metastases and of liver metastases compared with CT.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Hayashibe, M. Kameyama, M. Shinbo, and S. Makimoto Clinical Results on Intra-arterial Adjuvant Chemotherapy for Prevention of Liver Metastasis Following Curative Resection of Pancreatic Cancer Ann. Surg. Oncol., January 1, 2007; 14(1): 190 - 194. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-J. Lemke, S. M. Niehues, N. Hosten, H. Amthauer, M. Boehmig, C. Stroszczynski, T. Rohlfing, S. Rosewicz, and R. Felix Retrospective Digital Image Fusion of Multidetector CT and 18F-FDG PET: Clinical Value in Pancreatic Lesions--A Prospective Study with 104 Patients J. Nucl. Med., August 1, 2004; 45(8): 1279 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M K Kalra, M M Maher, P R Mueller, and S Saini State-of-the-art imaging of pancreatic neoplasms Br. J. Radiol., December 1, 2003; 76(912): 857 - 865. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
